Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR8 | Q9NR97 | 13/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | GLA | P06280 | 2/20 | 0.51 |
| ▸ | GAA | P10253 | 2/20 | 0.51 |
| ▸ | HPGD | P15428 | 2/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | CASP1 | P29466 | 1/20 | 0.51 |
| ▸ | CASP7 | P55210 | 1/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | PTBP1 | P26599 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.46 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8003645 | 1.00 | TLR8 (0.61) | TLR8KDM4EALDH1A1GLAGAA | |
| SCHEMBL21551636 | 1.00 | TLR8 (0.61) | TLR8KDM4EALDH1A1GLAGAA | |
| SCHEMBL3021416 | 1.00 | TLR8 (0.61) | TLR8KDM4EALDH1A1GLAGAA | |
| SCHEMBL4103521 | 1.00 | TLR8 (0.61) | TLR8KDM4EALDH1A1GLAGAA | |
| SCHEMBL2462921 | 1.00 | TLR8 (0.61) | TLR8KDM4EALDH1A1GLAGAA | |
| SCHEMBL916064 | 1.00 | TLR8 (0.61) | TLR8KDM4EALDH1A1GLAGAA | |
| SCHEMBL30593398 | 1.00 | TLR8 (0.61) | TLR8KDM4EALDH1A1GLAGAA | |
| SCHEMBL7600918 | 0.98 | TLR8 (0.61) | TLR8KDM4EALDH1A1GLAGAA | |
| SCHEMBL19656190 | 0.94 | TLR8 (0.60) | TLR8KDM4EALDH1A1GLAGAA | |
| SCHEMBL28491074 | 0.92 | ALDH1A1 (0.53) | TLR8KDM4EALDH1A1GLAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 149 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2964790-B1 | SIMPLIFIED NUCLEI ANALYSIS PLATFORM AND BIOMARKER MATRIX THAT SUPPORTS GENOTOXIC MODE OF ACTION DETERMINATIONS | LITRON LABORATORIES LTD (US) | 2023-06-07 | — | — | EP | claimed |
| EP-2267453-B1 | Method for a fully automated monoclonal antibody-based extended differential | BECKMAN COULTER INC (US) | 2016-08-17 | — | — | EP | claimed |
| EP-2964790-A1 | SIMPLIFIED NUCLEI ANALYSIS PLATFORM AND BIOMARKER MATRIX THAT SUPPORTS GENOTOXIC MODE OF ACTION DETERMINATIONS | Litron Laboratories, Ltd (US) | 2016-01-13 | — | — | EP | claimed |
| EP-1747460-B1 | METHOD FOR A FULLY AUTOMATED MONOCLONAL ANTIBODY-BASED EXTENDED DIFFERENTIAL | BECKMAN COULTER INC (US) | 2015-11-18 | — | — | EP | claimed |
| WO-2014164312-A1 | SIMPLIFIED NUCLEI ANALYSIS PLATFORM AND BIOMARKER MATRIX THAT SUPPORTS GENOTOXIC MODE OF ACTION DETERMINATIONS | LITRON LABORATORIES, LTD (US) | 2014-10-09 | — | — | WO | claimed |
| US-20140120564-A1 | NON-INVASIVE MEASUREMENT OF ANALYTES | CERCACOR LABORATORIES, INC. (US) | 2014-05-01 | — | — | US | claimed |
| US-8535226-B2 | Method for measuring in vivo hematotoxicity with an emphasis on radiation exposure assessment | LITRON LABORATORIES, LTD. (US) | 2013-09-17 | — | — | US | claimed |
| US-8509867-B2 | Non-invasive measurement of analytes | CERCACOR LABORATORIES, INC. (US) | 2013-08-13 | — | — | US | claimed |
| US-20120052509-A1 | METHOD FOR MEASURING IN VIVO HEMATOTOXICITY WITH AN EMPHASIS ON RADIATION EXPOSURE ASSESSMENT | LITRON LABORATORIES, LTD. (US) | 2012-03-01 | — | — | US | claimed |
| US-8062222-B2 | Method for measuring in vivo hematotoxicity with an emphasis on radiation exposure assessment | LITRON LABORATORIES, LTD. (US) | 2011-11-22 | — | — | US | claimed |
| US-20040106163-A1 | Non-invasive measurement of analytes | MASIMO LABORATORIES, INC. | 2004-06-03 | — | — | US | claimed |
| WO-2004044557-A2 | NON-INVASIVE MEASUREMENT OF ANALYTES | ARGOSE, INC. (US) | 2004-05-27 | — | — | WO | claimed |
| EP-1236044-A2 | DIAGNOSING AND TREATING ARTHRITIC DISORDERS | Mitokor (US) | 2002-09-04 | — | — | EP | claimed |
| EP-1210596-A2 | METHODS FOR ASSAYING SUBCELLULAR CONDITIONS USING ENERGY TRANSFER | MITOKOR (US) | 2002-06-05 | — | — | EP | claimed |
| EP-1181388-A2 | INDICATORS OF ALTERED MITOCHONDRIAL FUNCTION IN PREDICTIVE METHODS FOR DETERMINING RISK OF TYPE 2 DIABETES MELLITUS | MITOKOR (US) | 2002-02-27 | — | — | EP | claimed |
| US-6323039-B1 | CONTACTING SAMPLE COMPRISING ONE OR MORE MITOCHONDRIA WITH EACH OF FIRST AND SECOND ENERGY TRANSFER MOLECULE THAT IS NOT ENDOGENOUS TO THE MITOCHONDRIA; EXCITING ENERGY DONOR MOLECULE TO PRODUCE AN EXCITED ENERGY DONOR MOLECULE; DETECTING SIGNAL | MITOKOR | 2001-11-27 | — | — | US | claimed |
| WO-2001020018-A2 | DIAGNOSING AND TREATING ARTHRITIC DISORDERS | MITOKOR (US) | 2001-03-22 | — | — | WO | claimed |
| WO-2000079274-A2 | METHODS FOR ASSAYING SUBCELLULAR CONDITIONS USING ENERGY TRANSFER | MITOKOR (US) | 2000-12-28 | — | — | WO | claimed |
| WO-2000066762-A2 | INDICATORS OF ALTERED MITOCHONDRIAL FUNCTION IN PREDICTIVE METHODS FOR DETERMINING RISK OF TYPE 2 DIABETES MELLITUS | MITOKOR (US) | 2000-11-09 | — | — | WO | claimed |
| US-6140067-A | IDENTIFYING AN AGENT SUITABLE FOR TREATING A HUMAN SUBJECT SUSPECTED OF BEING AT RISK FOR HAVING TYPE 2 DIABETES | MITOKOR (US) | 2000-10-31 | — | — | US | claimed |